Skip to NavigationSkip to content

News

The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the most common form of brain...
Valeant CEO, Joseph Papa, said that the company would focus on launching new products, instead of selling parts of the business, to maintain its...
Researchers at Ohio State University have discovered that, as well as forming a key part of treatment strategies to fight breast cancer,...
It has been revealed that manufacturing issues could cause severe shortages to administer the hepatitis B vaccine to those in need.
In research that will have many women nodding their brain-boxes, a study has found that analysis of thousands of brain scans showed that women had...
It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move to prepare for this after signing a licensing...
NICE has decided to expand its recommendation of Erbitux (cetuximab) to include its use as a first-line treatment for recurrent or metastatic...
Shire has sold off its 340,000-square-foot facility that was leftover from the Baxalta deal to MSD Animal Health.
The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave draft guidance recommending...
Zynerba Pharmaceuticals had hoped that its anti-seizure therapy could replicate the kind of success leading competitors had achieved in showing...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches